Lobaplatin in Prophylactic Hyperthermic Intraperitoneal Chemotherapy for Advanced Gastric Cancer: Safety and Efficacy Profiles.

Yuxin ZhongJing ZhangXiaofeng BaiYuemin SunHao LiuShuai MaYang LiWenzhe KangFuhai MaWeikun LiYantao Tian

Published in: Cancer management and research (2020)

Lobaplatin in prophylactic HIPEC is safe for advanced gastric cancer patients after treatment by radical resection and can effectively improve illness-specific 3-year disease-free survival.

Keyphrases

free survival
neoadjuvant chemotherapy
locally advanced
rectal cancer